Physician profile
Stephanie Hall
NPI 1750582979
$393.44
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $13.44 · 2021: $16.12 · 2022: $101 · 2023: $31.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $31.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $31.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $62.77 | 2019 | |
| Abbvie INC. | $39.34 | 2021-2022 | |
| Baxter Healthcare | $31.73 | 2023 | Tisseel |
| Roche Diagnostics Corporation | $31.37 | 2019 | |
| Avion Pharmaceuticals | $29.80 | 2019 | |
| Therapeuticsmd, INC. | $25.76 | 2019-2022 | |
| Gilead Sciences, INC. | $20.64 | 2019 | |
| Novo Nordisk INC | $20.40 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.44 | 2022 | |
| Sage Therapeutics, LLC | $17.13 | 2022 | |
| Mayne Pharma Commercial LLC | $17.02 | 2022 | |
| Pfizer INC. | $14.00 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.58 | 2019 | |
| Amgen INC. | $13.49 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.44 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $12.89 | 2019 | |
| Medtronic, INC. | $11.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.